A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.

Saved in:
Bibliographic Details
Title: A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
Authors: Ademuyiwa FO; Washington University School of Medicine, St Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu., Gao F; Washington University School of Medicine, St Louis, MO, 63110, USA., Street CR; Washington University School of Medicine, St Louis, MO, 63110, USA., Chen I; Washington University School of Medicine, St Louis, MO, 63110, USA., Northfelt DW; Mayo Clinic, Phoenix, AZ, 85054, USA., Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA., Arora M; UC Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA., Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA., Dees EC; University of North Carolina School of Medicine, Chapel Hill, NC, 27514, USA., Santa-Maria CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA., Connolly RM; University College Cork, Cork, Ireland., Force J; Duke University School of Medicine, Durham, NC, 27710, USA., Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, 32224, USA., Herndon JM; Washington University School of Medicine, St Louis, MO, 63110, USA., Carmody M; Washington University School of Medicine, St Louis, MO, 63110, USA., Davies SR; Washington University School of Medicine, St Louis, MO, 63110, USA., Larson S; Washington University School of Medicine, St Louis, MO, 63110, USA., Pfaff KL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Jones SM; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Weirather JL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Giobbie-Hurder A; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Rodig SJ; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA., Liu Z; Washington University School of Medicine, St Louis, MO, 63110, USA., Hagemann IS; Washington University School of Medicine, St Louis, MO, 63110, USA., Sharon E; National Cancer Institute, Bethesda, MD, 20892, USA., Gillanders WE; Washington University School of Medicine, St Louis, MO, 63110, USA. gillandersw@wustl.edu.
Source: NPJ breast cancer [NPJ Breast Cancer] 2022 Dec 30; Vol. 8 (1), pp. 134. Date of Electronic Publication: 2022 Dec 30.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36585404
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ademuyiwa+FO%22">Ademuyiwa FO</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu.<br /><searchLink fieldCode="AU" term="%22Gao+F%22">Gao F</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Street+CR%22">Street CR</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Chen+I%22">Chen I</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Northfelt+DW%22">Northfelt DW</searchLink>; Mayo Clinic, Phoenix, AZ, 85054, USA.<br /><searchLink fieldCode="AU" term="%22Wesolowski+R%22">Wesolowski R</searchLink>; Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.<br /><searchLink fieldCode="AU" term="%22Arora+M%22">Arora M</searchLink>; UC Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA.<br /><searchLink fieldCode="AU" term="%22Brufsky+A%22">Brufsky A</searchLink>; University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.<br /><searchLink fieldCode="AU" term="%22Dees+EC%22">Dees EC</searchLink>; University of North Carolina School of Medicine, Chapel Hill, NC, 27514, USA.<br /><searchLink fieldCode="AU" term="%22Santa-Maria+CA%22">Santa-Maria CA</searchLink>; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA.<br /><searchLink fieldCode="AU" term="%22Connolly+RM%22">Connolly RM</searchLink>; University College Cork, Cork, Ireland.<br /><searchLink fieldCode="AU" term="%22Force+J%22">Force J</searchLink>; Duke University School of Medicine, Durham, NC, 27710, USA.<br /><searchLink fieldCode="AU" term="%22Moreno-Aspitia+A%22">Moreno-Aspitia A</searchLink>; Mayo Clinic, Jacksonville, FL, 32224, USA.<br /><searchLink fieldCode="AU" term="%22Herndon+JM%22">Herndon JM</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Carmody+M%22">Carmody M</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Davies+SR%22">Davies SR</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Larson+S%22">Larson S</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Pfaff+KL%22">Pfaff KL</searchLink>; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Jones+SM%22">Jones SM</searchLink>; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Weirather+JL%22">Weirather JL</searchLink>; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Giobbie-Hurder+A%22">Giobbie-Hurder A</searchLink>; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Rodig+SJ%22">Rodig SJ</searchLink>; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Liu+Z%22">Liu Z</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Hagemann+IS%22">Hagemann IS</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA.<br /><searchLink fieldCode="AU" term="%22Sharon+E%22">Sharon E</searchLink>; National Cancer Institute, Bethesda, MD, 20892, USA.<br /><searchLink fieldCode="AU" term="%22Gillanders+WE%22">Gillanders WE</searchLink>; Washington University School of Medicine, St Louis, MO, 63110, USA. gillandersw@wustl.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2022 Dec 30; Vol. 8 (1), pp. 134. <i>Date of Electronic Publication: </i>2022 Dec 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36585404
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-022-00500-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 134
    Titles:
      – TitleFull: A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ademuyiwa FO
      – PersonEntity:
          Name:
            NameFull: Gao F
      – PersonEntity:
          Name:
            NameFull: Street CR
      – PersonEntity:
          Name:
            NameFull: Chen I
      – PersonEntity:
          Name:
            NameFull: Northfelt DW
      – PersonEntity:
          Name:
            NameFull: Wesolowski R
      – PersonEntity:
          Name:
            NameFull: Arora M
      – PersonEntity:
          Name:
            NameFull: Brufsky A
      – PersonEntity:
          Name:
            NameFull: Dees EC
      – PersonEntity:
          Name:
            NameFull: Santa-Maria CA
      – PersonEntity:
          Name:
            NameFull: Connolly RM
      – PersonEntity:
          Name:
            NameFull: Force J
      – PersonEntity:
          Name:
            NameFull: Moreno-Aspitia A
      – PersonEntity:
          Name:
            NameFull: Herndon JM
      – PersonEntity:
          Name:
            NameFull: Carmody M
      – PersonEntity:
          Name:
            NameFull: Davies SR
      – PersonEntity:
          Name:
            NameFull: Larson S
      – PersonEntity:
          Name:
            NameFull: Pfaff KL
      – PersonEntity:
          Name:
            NameFull: Jones SM
      – PersonEntity:
          Name:
            NameFull: Weirather JL
      – PersonEntity:
          Name:
            NameFull: Giobbie-Hurder A
      – PersonEntity:
          Name:
            NameFull: Rodig SJ
      – PersonEntity:
          Name:
            NameFull: Liu Z
      – PersonEntity:
          Name:
            NameFull: Hagemann IS
      – PersonEntity:
          Name:
            NameFull: Sharon E
      – PersonEntity:
          Name:
            NameFull: Gillanders WE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 30
              M: 12
              Text: 2022 Dec 30
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1